FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2537416735> ?p ?o ?g. }

• W2537416735 endingPage "5189" @default.
• W2537416735 startingPage "5183" @default.
• W2537416735 abstract "Neoadjuvant chemotherapy (NAC) followed by hysterectomy may be effective for the treatment of locally advanced uterine cervical cancer and improve patient prognosis. It is important to identify markers that are able to predict whether NAC may be successful. Epidermal growth factor-like domain 7 (EGFL7) regulates vascular sprouting in blood vessel formation. In numerous types of human cancer, EGFL7 is upregulated and inhibits endothelial cell adhesion molecules, decreasing vascular tightness and, thus, increasing vascular permeability. It is considered that the overexpression of EGFL7 is able to inhibit drug delivery, resistance to apoptosis and the epithelial-to-mesenchymal transition. In the current study, 63 patients with locally advanced uterine cervical cancer were reviewed and classified as stage IIIA-IIIB using the International Federation of Gynecology and Obstetrics criteria. These patients (aged <70 years) were treated at Osaka City University Medical School Hospital, Japan, between 1995 and 2010. Tumor tissue samples were obtained by biopsy prior to NAC. The tissue samples were classified as group 1 or 2 depending on the efficacy of NAC. Surgery and radiotherapy were administered in group 1 (n=36), for which NAC was effective. In the patients of group 2 NAC was not effective, and radiotherapy alone was administered (n=27). The expression of EGFL7 and Snail was examined in paraffin-embedded tissue sample sections using the avidin-biotin peroxidase complex method. The results indicated that EGFL7 expression levels were significantly higher in group 2, as compared with group 1 (P<0.001). A similar result was observed for the expression levels of Snail (P=0.001). Group 1 exhibited significantly longer overall survival times compared with group 2 (P=0.001). The patients were also classified into a low EGFL7 expression level group (weighted score of ≤6) and a high EGFL7 expression level group (weighted score of ≥8). NAC was observed to be significantly more effective in the low EGFL7 expression level group (P<0.001), as compared with the high expression level group. The results suggest that the expression levels of EGFL7 may be a potential predictive marker of the efficacy of NAC for the treatment of locally advanced uterine cervical cancer." @default.
• W2537416735 created "2016-10-28" @default.
• W2537416735 creator A5001196940 @default.
• W2537416735 creator A5002025978 @default.
• W2537416735 creator A5015074866 @default.
• W2537416735 creator A5022640516 @default.
• W2537416735 creator A5042218973 @default.
• W2537416735 creator A5056126248 @default.
• W2537416735 creator A5059458078 @default.
• W2537416735 creator A5073508224 @default.
• W2537416735 date "2016-10-25" @default.
• W2537416735 modified "2023-10-13" @default.
• W2537416735 title "Expression of epidermal growth factor-like domain 7 may be a predictive marker of the effect of neoadjuvant chemotherapy for locally advanced uterine cervical cancer" @default.
• W2537416735 cites W1942577196 @default.
• W2537416735 cites W1971467136 @default.
• W2537416735 cites W1972271586 @default.
• W2537416735 cites W2000979607 @default.
• W2537416735 cites W2005852730 @default.
• W2537416735 cites W2006202974 @default.
• W2537416735 cites W2011554967 @default.
• W2537416735 cites W2013651485 @default.
• W2537416735 cites W2028305184 @default.
• W2537416735 cites W2028676677 @default.
• W2537416735 cites W2029874297 @default.
• W2537416735 cites W2029922807 @default.
• W2537416735 cites W2031222466 @default.
• W2537416735 cites W2034760388 @default.
• W2537416735 cites W2038870684 @default.
• W2537416735 cites W2052918460 @default.
• W2537416735 cites W2065629669 @default.
• W2537416735 cites W2068105015 @default.
• W2537416735 cites W2074654130 @default.
• W2537416735 cites W2075087741 @default.
• W2537416735 cites W2078134150 @default.
• W2537416735 cites W2079396993 @default.
• W2537416735 cites W2083049266 @default.
• W2537416735 cites W2088303571 @default.
• W2537416735 cites W2094530722 @default.
• W2537416735 cites W2097945491 @default.
• W2537416735 cites W2103504619 @default.
• W2537416735 cites W2106630697 @default.
• W2537416735 cites W2106787323 @default.
• W2537416735 cites W2109998353 @default.
• W2537416735 cites W2146625800 @default.
• W2537416735 cites W2156407852 @default.
• W2537416735 cites W2159830370 @default.
• W2537416735 cites W2163588562 @default.
• W2537416735 cites W2263001779 @default.
• W2537416735 cites W2319112953 @default.
• W2537416735 cites W2324392028 @default.
• W2537416735 doi "https://doi.org/10.3892/ol.2016.5318" @default.
• W2537416735 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5228482" @default.
• W2537416735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28105226" @default.
• W2537416735 hasPublicationYear "2016" @default.
• W2537416735 type Work @default.
• W2537416735 sameAs 2537416735 @default.
• W2537416735 citedByCount "9" @default.
• W2537416735 countsByYear W25374167352018 @default.
• W2537416735 countsByYear W25374167352019 @default.
• W2537416735 countsByYear W25374167352020 @default.
• W2537416735 countsByYear W25374167352021 @default.
• W2537416735 countsByYear W25374167352023 @default.
• W2537416735 crossrefType "journal-article" @default.
• W2537416735 hasAuthorship W2537416735A5001196940 @default.
• W2537416735 hasAuthorship W2537416735A5002025978 @default.
• W2537416735 hasAuthorship W2537416735A5015074866 @default.
• W2537416735 hasAuthorship W2537416735A5022640516 @default.
• W2537416735 hasAuthorship W2537416735A5042218973 @default.
• W2537416735 hasAuthorship W2537416735A5056126248 @default.
• W2537416735 hasAuthorship W2537416735A5059458078 @default.
• W2537416735 hasAuthorship W2537416735A5073508224 @default.
• W2537416735 hasBestOaLocation W25374167351 @default.
• W2537416735 hasConcept C121608353 @default.
• W2537416735 hasConcept C126322002 @default.
• W2537416735 hasConcept C142724271 @default.
• W2537416735 hasConcept C143998085 @default.
• W2537416735 hasConcept C167734588 @default.
• W2537416735 hasConcept C170493617 @default.
• W2537416735 hasConcept C2776362946 @default.
• W2537416735 hasConcept C2776694085 @default.
• W2537416735 hasConcept C2777025900 @default.
• W2537416735 hasConcept C2778220009 @default.
• W2537416735 hasConcept C2779013556 @default.
• W2537416735 hasConcept C2781018059 @default.
• W2537416735 hasConcept C29537977 @default.
• W2537416735 hasConcept C509974204 @default.
• W2537416735 hasConcept C67082663 @default.
• W2537416735 hasConcept C71924100 @default.
• W2537416735 hasConcept C76419328 @default.
• W2537416735 hasConceptScore W2537416735C121608353 @default.
• W2537416735 hasConceptScore W2537416735C126322002 @default.
• W2537416735 hasConceptScore W2537416735C142724271 @default.
• W2537416735 hasConceptScore W2537416735C143998085 @default.
• W2537416735 hasConceptScore W2537416735C167734588 @default.
• W2537416735 hasConceptScore W2537416735C170493617 @default.
• W2537416735 hasConceptScore W2537416735C2776362946 @default.
• W2537416735 hasConceptScore W2537416735C2776694085 @default.
• W2537416735 hasConceptScore W2537416735C2777025900 @default.

• next